Longboard Pharmaceuticals, Inc. (LBPH) Misses Q3 EPS by 5c

Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.63), $0.05 worse than the analyst estimate of ($0.58).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• NSA lost access to powerful AI model amid Anthropic dispute - NYT
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat